Skip to main content
. 2023 Aug 14;17:1589. doi: 10.3332/ecancer.2023.1589

Table 2. Univariate analysis of PFS and OS.

Factors PFS (months) p-value OS (months) p-value
ECOG PS
(1 versus 2 versus 3)
25.9 versus 7.5 versus 4.9 0.015 27 versus NR versus 13 0.416
Site of metastases
(Bone only versus Nodal/visceral)
7.7 versus 9.1 0.690 28.7 versus 27.3 0.570
Prior docetaxel (yes versus no) 7.4 versus 8.2 0.459 27.5 versus NR 0.622
Prior abiraterone acetate (yes versus no) 11 versus 7 0.060 28.7 versus 15 <0.001
PSA response 12 versus 5 0.001 NR versus 21 0.027